Search Orphan Drug Designations and Approvals
-
Generic Name: | ribavirin elaidate |
---|---|
Date Designated: | 09/02/2011 |
Orphan Designation: | Treatment of follicular, medullary, and anaplastic thyroid carcinoma and metastatic or locally advanced papillary thyroid cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Translational Therapeutics, Inc. 163 Scituate Street Arlington, Massachusetts 02476 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-